I. Assessment A. Policy and Research Question Policy Question: Should ECMO for COVID-19 patients with acute respiratory distress syndrome (ARDS) be recommended for use and covered by PhilHealth? Research Questions: Treatment guidelines and evidence synthesis on the use of ECMO Clinical efficacy / effectiveness and safety Among critically ill COVID-19 patients continue reading : Extracorporeal Membrane Oxygenation (ECMO) for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)
Rapid antibody tests (RATs) (May 2020 reassessment)
I. Assessment A. Policy and Research Question Policy Question: Which use case and for what population should the Philippine DOH consider the use of RATs? Research Questions: Regulatory Approval Testing guidelines and evidence synthesis on use of RATs Diagnostic Performance a. Diagnosis of COVID-19 among asymptomatic patients b. Determination of previous exposure continue reading : Rapid antibody tests (RATs) (May 2020 reassessment)
Pneumococcal Conjugate Vaccine 13 (PCV-13)(2020 Reassessment)
Date of Publication: October 15, 2020 Objectives: HTA Full Report: Reassessment of 10- versus 13-valent Pneumococcal Conjugate Vaccines (PCV) in the Philippines Evidence summary: PCV ES OSEC Approved
Reverse Transcriptase – Polymerase Chain Reaction (RT-PCR)
I. Assessment A. Policy and Research Question Policy Question: Which SARS-CoV-2 PCR test kit brand/s may be procured by the Philippine DOH for detecting COVID19 cases among suspect cases and recovering patients? Research Questions: Market availability and implementation Performance: Accuracy or Agreement Measures Resource requirements B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. continue reading : Reverse Transcriptase – Polymerase Chain Reaction (RT-PCR)
AMTI uAI-Discover-PNA
I. Assessment A. Policy and Research Question Policy Question: Should the Department of Health accept the donation of the AMTI uAI-Discover-PNA for COVID-19 in the Philippines? Research Questions: B. Protocol: Not available. C. Reviewers: Health Technology Assessment Unit, DOH D. Start of Review: Not available. E. End of Review: April 14, 2020 II. Recommendation Evidence summary: AMTI uAI-Discover-PNA Rapid review: Pending continue reading : AMTI uAI-Discover-PNA